Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 28-12-2015 |
Asset Class: Equity |
Benchmark: NIFTY Pharma TRI |
TER: 2.15% As on (30-04-2025) |
Status: Open Ended Schemes |
Minimum Investment: 5000.0 |
Minimum Topup: 1000.0 |
Total Assets: 1,223 Cr As on 30-04-2025(Source:AMFI) |
Turn over: 22.57% | Exit Load: 0.25% of NAV if redeemed /switched out before 30 days from the date of allotment. |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Standard Deviation | 14.23 |
Sharpe Ratio | 0.66 |
Alpha | 1.89 |
Beta | 0.92 |
Yield to Maturity | - |
Average Maturity | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
30.54%
Others
6.57%
Large Cap
30.19%
Mid Cap
32.7%